Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04806399 · ClinicalTrials.gov registry record · NA

Improving Utilization of Lung Cancer Screening in Underserved PA Populations

A NA study of Lung Cancer, sponsored by American College of Radiology.

Active
Registry status
NA
Development phase
2,500
Enrollment target
2
Study locations

NCT04806399 is a NA study of Lung Cancer that is active but no longer recruiting, run by American College of Radiology. The registered enrollment target is 2,500 participants, above the 930-participant average among 409 other Lung Cancer trials with a reported enrollment target (169% higher). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04806399, a NA study of Lung Cancer, is active but no longer recruiting, sponsored by American College of Radiology.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
2,500 participants
Enrollment target
2
Study locations

Study Summary

This study is an interventional study intended to assess the impact of a centralized outreach intervention that includes shared decision-making about lung cancer screening (LCS) in LCS-eligible primary care patients. The study's goal is to increase LCS rates compared to usual care and thus reduce lung cancer deaths.

Conditions Studied

Interventions

  • OTHER Educational Materials and Decision Counseling

Study Locations (2)

Pennsylvania

  • Lehigh Valley Health Network - Allentown
  • Jefferson Health System - Philadelphia

Trial Details

FieldValue
Enrollment Target 2,500 participants
Start Date 2023-03-30
Est. Completion 2024-11
Phase NA

Sponsor

American College of Radiology

14 total trials

What the Registry Record Tells You About NCT04806399

The ClinicalTrials.gov registry entry for NCT04806399 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 2,500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 930-participant average among 409 other Lung Cancer trials with a reported enrollment target (169% higher). The listed sponsor is American College of Radiology, which has 14 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 1 intervention - of which Educational Materials and Decision Counseling is the first listed.

NCT04806399 reports 2 study locations spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT04806399 about?

NCT04806399 is a clinical study titled "Improving Utilization of Lung Cancer Screening in Underserved PA Populations". This study is an interventional study intended to assess the impact of a centralized outreach intervention that includes shared decision-making about lung cancer screening (LCS) in LCS-eligible primary care patients. The study's goal is to increase LCS rates compared to usual care and thus reduce lu...

What is the current status of trial NCT04806399?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 2,500 participants. The study started on 2023-03-30. Estimated completion is 2024-11.

What conditions does trial NCT04806399 study?

This clinical trial studies the following conditions: Lung Cancer.

What interventions are being tested in trial NCT04806399?

The interventions under investigation include: Educational Materials and Decision Counseling (OTHER).

Who is sponsoring clinical trial NCT04806399?

This trial is sponsored by American College of Radiology, which has 14 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04806399 being conducted?

This trial has 2 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Lung Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.